Neoplasms: all 9,617 studies
Page 51 of 97. Open to participants first (2,509), then studies with results posted, then the rest; newest registration first within each.
- A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid TumorsWithdrawnNCT05039931Phase 1
- Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at WorkWithdrawnNCT05038384
- Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System.Status unknownNCT05036798Phase 2
- Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Multimodal Nonpharmacological SolutionsCompletedNCT05036408Not applicable
- Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDOActive, not recruitingNCT05033756Phase 2
- Toxicity of Treatments for Non-tuberculous Mycobacterial Infections in Cancer Patients or NotCompletedNCT05030701
- A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic MalignanciesStatus unknownNCT05028478Phase 1/2
- EP Combined With RFA for Ampullary Neoplasms With Intraductal Biliary ExtensionCompletedNCT05028465Not applicable
- A Clinical Study of TQB3824 in Subjects With Advanced CancerStatus unknownNCT05028218Phase 1
- Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer.TerminatedNCT05025514
- A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid TumorCompletedNCT05024331
- Safety, Tolerability, PK, PD, Immunogenicity and Efficacy of TWP-102 in Patients With Advanced Malignancies.Status unknownNCT05024305Phase 1
- Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve BlockStatus unknownNCT05022160Early Phase 1
- Interactive Mobile Doctor (iMD) to Promote Tobacco Cessation Among Cancer PatientsCompletedNCT05021185Not applicable
- A Study of TQB3820 in Patients With Hematological MalignanciesStatus unknownNCT05020639Phase 1
- Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin LymphomaActive, not recruitingNCT05019976Not applicable
- Study of VB10.NEO in Combination With Atezolizumab in Solid TumorsCompletedNCT05018273Phase 1
- Cancer Financial ExperienceCompletedNCT05018000Not applicable
- A Study to Evaluate YH003 in Subjects With Advanced Solid TumorsCompletedNCT05017623Phase 1
- A Study to Investigate Safety and Tolerability of SH3765 Tablet in Patients With Advanced Malignant TumorStatus unknownNCT05015309Phase 1
- Neuroendocrine Neoplasms Methylation Based Classifier - The NEMESIs-studyCompletedNCT05013957
- Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid TumorsTerminatedNCT05013554Phase 1
- GH35 Tablets for Advanced Solid Tumors: A Study on Safety and Early ResultsActive, not recruitingNCT05010694Phase 1
- A Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG 016 Monotherapy in Patients With Advanced Solid TumorsTerminatedNCT05010525Phase 1/2
- BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid TumorsWithdrawnNCT05010096Phase 1
- Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic MalignancyCompletedNCT05009719Phase 1/2
- Study of LM-102 in Patients With Advance Solid TumorsTerminatedNCT05008445Phase 1/2
- Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular CarcinomaStatus unknownNCT05006326Not applicable
- Early Feasibility Study of the "Easy Light" Fluorecence Imaging SystemCompletedNCT05004623Not applicable
- PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell MalignanciesStatus unknownNCT05003141Phase 1
- Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid TumorsCompletedNCT05001516Phase 1
- A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)TerminatedNCT05001282Phase 1/2
- Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention TrainingWithdrawnNCT05000905Not applicable
- Effect of Pelvic Radiotherapy on the Intestinal Microbiome and MetabolomeCompletedNCT04995809
- A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid TumorsCompletedNCT04991506Phase 1
- FAPI PET/CT Prospective Interobserver AgreementCompletedNCT04990882
- Exercise and Tumor Blood Flow in Lymphoma And Breast Cancer Patients (EXETUMOR 3)Status unknownNCT04990856Not applicable
- Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid TumorsStatus unknownNCT04990739Phase 1
- Study of INCA 0186 in Subjects With Advanced Solid TumorsTerminatedNCT04989387Phase 1
- Dose Efficiency of Modern CT Scanners in Oncologic ScansStatus unknownNCT04989192Not applicable
- Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid TumorsStatus unknownNCT04989010Not applicable
- A Trial of a Multimodal Lifestyle Intervention to Optimize Survivorship After CancerCompletedNCT04987359Not applicable
- Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING StudyWithdrawnNCT04987281Phase 2
- A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin LymphomasTerminatedNCT04986865Phase 1
- Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric CancerCompletedNCT04984733Phase 2
- 89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid TumorsStatus unknownNCT04977128Not applicable
- Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)Active, not recruitingNCT04976634Phase 2
- TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid TumorsStatus unknownNCT04976218Phase 1
- Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid TumorsCompletedNCT04975958Phase 1
- Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)TerminatedNCT04975256Phase 1
- A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant TumorsStatus unknownNCT04975204Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid TumorsCompletedNCT04972981Phase 1
- The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in FemaleStatus unknownNCT04969445
- Accelerated Neuromodulation to Alleviate Cognitive Deficits Due to Cancer TherapyCompletedNCT04966520Not applicable
- Nurse Navigation Program Based On Health Belief Model In Breast Cancer Screening (NaHeB-CaS)CompletedNCT04966377Not applicable
- Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)Active, not recruitingNCT04964934Phase 3
- Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing SurgeryStatus unknownNCT04963972Not applicable
- Idylla EGFR Lung TrialStatus unknownNCT04962191
- NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNtsCompletedNCT04960059
- Study of TST005 in Patients With Locally Advanced or Metastatic Solid TumorsTerminatedNCT04958434Phase 1
- A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck CancerActive, not recruitingNCT04958239Phase 1
- A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid TumoursCompletedNCT04958226Phase 1
- Clinical Study of JS201 in Patients With Advanced Malignant TumorsStatus unknownNCT04956926Phase 1
- A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative NeoplasmsWithdrawnNCT04955938Phase 1
- A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic MalignanciesStatus unknownNCT04954456Phase 1
- B-cell Chronic Lymphoid Malignancies MarkersStatus unknownNCT04952974
- Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention StudyCompletedNCT04952961Not applicable
- Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy AdultsCompletedNCT04952766Phase 4
- Aesthetic and Functional Outcomes of Eyelid Reconstruction After Excision of Periocular TumorsStatus unknownNCT04952116Not applicable
- Randomized Clinical Trial Comparing Conventional Laparoscopic Surgery and Robot-Assisted Laparoscopic Surgery for the Treatment of Parastomal Hernia of the Oncology PatientStatus unknownNCT04950140Not applicable
- A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid TumoursTerminatedNCT04949425Phase 1
- A Contemporary Review of Surgical Approaches in Pelvic Exenterative SurgeryStatus unknownNCT04948762
- Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile NeutropeniaCompletedNCT04948463Phase 4
- A Study of N9 Chemotherapy in Children With NeuroblastomaActive, not recruitingNCT04947501Early Phase 1
- Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLCActive, not recruitingNCT04945928Not applicable
- New Models for the Evaluation of Preclinical Treatment for Urothelial Carcinomas of the Upper Excretory Tract.CompletedNCT04944550
- A Study of BMS-986416 With and Without Nivolumab in Select Solid TumorsCompletedNCT04943900Phase 1
- CD19 CAR T Cells in Children and Adults With Relapsed or Refractory CD19 Positive B Cell MalignanciesStatus unknownNCT04943016Phase 1
- A Study of MRG002 in the Treatment of Patients With HER2-positive Advanced Solid TumorsStatus unknownNCT04941339Phase 1
- Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline TherapyActive, not recruitingNCT04939883Phase 4
- Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active CancerCompletedNCT04938869Not applicable
- Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid TumorsStatus unknownNCT04934514Phase 1/2
- A Study of ET-02 in Patients With Relapsed or Refractory B-cell Malignancy(NHL/ALL)Status unknownNCT04933825Not applicable
- LPN in Patients With High-complex Renal TumorsCompletedNCT04933604
- Use of nMoABs for the Treatment of COVID-19 in Patients With HM.CompletedNCT04932967
- BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active TreatmentCompletedNCT04932863
- Oral Symptom Assessment Scale (OSAS): Validity and ReliabilityCompletedNCT04932317
- Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsTerminatedNCT04931823Phase 1
- Neuroendocrine Neoplasm Based on Multi-omics Integrated AnalysisStatus unknownNCT04931446
- 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation TherapyTerminatedNCT04928820Phase 2
- Single-cell Sequencing and Establishment of Models in Neuroendocrine NeoplasmStatus unknownNCT04927611
- XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)CompletedNCT04926545Not applicable
- Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative NeoplasmCompletedNCT04926194Phase 2
- Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)Status unknownNCT04922047Phase 1/2
- A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid TumorsCompletedNCT04921878Phase 1
- ALPN-202 With PD-1 Inhibition in Advanced MalignanciesTerminatedNCT04920383Phase 1
- A Study of a Telemedicine Program for Older Adults With CancerActive, not recruitingNCT04917848Not applicable
- Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer SurvivorsActive, not recruitingNCT04916249Phase 2
- Study of IBI323 in Patients With Advanced MalignanciesStatus unknownNCT04916119Phase 1
- Validation of an Electronic Remote Toxicity Management System in Cancer PatientsCompletedNCT04915274Not applicable